Linked Life Data

15920966

Source:http://linkedlifedata.com/resource/pubmed/id/15920966

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-5-30
pubmed:abstractText
This review aims to provide an overview of prostate brachytherapy and disseminate consensus guidelines formed by the American Brachytherapy Society. In Japan, permanent transperineal prostate brachytherapy with I-125 started in September 2003. Patients with high probability of organ-confined disease are appropriately treated with brachytherapy. Brachytherapy candidates with a significant risk of extraprostatic extension should be treated with supplemental external beam radiation therapy. The recommended prescription doses for monotherapy are 145 Gy. The corresponding boost doses after 40-50 Gy of external beam are 100-110 Gy. Dosimetric planning of the implant should be carried out for all patients before seed insertion. Post-implant dosimetry and evaluation must be performed on all patients. A dose-volume histogram of the prostate should be performed. The dose that covers 90% of the prostate volume, the percentage of prostate volume receiving 100%, 150%, and 200% of the prescribed dose, and the rectal dose and urethral dose should be reported. ABS recommends standardization of the reporting of brachytherapy-related prostate morbidity, including urinary, rectal, and sexual function. These morbidities should be correlated with the doses to normal tissues. High-dose-rate (HDR) brachytherapy with Ir- 192 has preceded seed implants in Japan. HDR has some theoretical advantages. We should develop techniques of both types of brachytherapy in Japan.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0048-0428
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
87-91
pubmed:dateRevised
2011-7-26
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
[Brachytherapy for prostate carcinoma].
pubmed:affiliation
Department of Radiology, Tokyo Medical Center, National Hospital Organization.
pubmed:publicationType
Journal Article, English Abstract, Review